A Study of Visual Outcomes and Spectral Domain Optical Coherence Tomography (SD-OCT) Biomarker Changes in Patients Treated With Ranibizumab for Diabetic Macular Edema in a Tertiary Hospital
Intravitreal ranibizumab significantly improves visual acuity and reduces retinal thickness in DME patients. SD-OCT biomarkers are valuable in monitoring treatment response and disease progression.
Authors
- K. Ravi Kumar
- Muniza Malik
- Rashmitha Somagani
- Rohan Somagani
Institutions
- Novartis (India) (IN)
- Employees' State Insurance Model Hospital (IN)
Publication Details
- Journal
- Cureus
- Published
- 2025-04-18
- DOI
- https://doi.org/10.7759/cureus.82520
- Citations
- 2
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.41